MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that James A. Schoeneck has joined Depomed’s board of directors. Mr. Schoeneck, 50, is currently chief executive officer of BrainCells Inc., a private biopharmaceutical company in San Diego, California, and brings to Depomed considerable executive and entrepreneurial leadership experience in the life sciences industry.
